ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

CD56-Negative Extranodal Natural Killer/T-Cell Lymphoma: A Retrospective Study in 443 Patients Treated by Chemotherapy With or Without Asparaginase

Yang, Jing; Li, Pengfei; Piao, Yingshi; Liu, Xindi; Wei, Liqiang; Sang, Wei*; Zhang, Luo*; Wang, Liang*北京航空航天大学; 南方医科大学; 中山大学
Frontiers in Immunology2022-3-17DOI: 10.3389/fimmu.2022.829366
1被引5阅读
引用收藏
分享

摘要

Objective: Extranodal natural killer/T cell lymphoma (NKTCL) is an aggressive EBV-related lymphoma, originating from NK cells or T cells. Previous study demonstrated that CD56 negative NKTCL should be recognized as a distinct subtype. In this study, the value of CD56 in NKTCL is validated in the era of asparaginase, and genomic analysis was done to dissect the differences between CD56-negative and positive NKTCL. @@@ Methods: 443 patients with newly diagnosed NKTCL were enrolled in this retrospective study, and correlation between CD56 positivity and survival outcomes was analyzed. The gene sequencing data was downloaded (http://www.biosino.org/node/project/detail/OEP000498), and bioinformatics analysis was done to delineate the tumor microenvironment and differentially expressed genes. @@@ Results: CD56 was expressed in 337 patients (76.1%). Within a median follow-up time of 51 months, the 5-year overall survival (OS) and progression free survival (PFS) rates were 63.8% and 51.9%, respectively. For the whole cohort, patients who were CD56-positive had superior OS (5-year OS, 86.2% vs. 51.9%, p=0.019) and PFS (5-year PFS, 55.9% vs. 40.1%, p=0.016). For patients in early stage disease, CD56 positivity was associated with superior OS and PFS (p=0.008 and 0.005, respectively). In patients who received nonasparaginase-based chemotherapy, CD56-negative was associated with shorter OS and PFS (p<0.001), and in patients who received asparaginase-based chemotherapy, CD56-negative was not related to inferior OS and PFS (p=0.093 and p=0.829, respectively). The genomic analysis demonstrated that CD56 positive NKTCL probably originated from NK cells and CD56 negative NKTCL originated from T cells. CD56 positive NKTCL had significantly higher proportion of resting NK cells, activated NK cells, and activated CD8+ and CD4+ T cells in the tumor microenvironment. @@@ Conclusions: CD56 negative NKTCL differs from CD56 positive NKTCL in both the tumor microenvironment and survival outcomes, and asparaginase-based treatment may overcome the poor prognosis brought by CD56 negativity.

学科与关键词

关键词
extranodal natural killer/T cell lymphomatumor microenvironmentprognosisasparaginasebioinformatics analysis
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Frontiers in Immunology
发表日期
2022-03-17
卷期
第 13 卷
页码
829366
DOI
10.3389/fimmu.2022.829366
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81873450, 82170181]; Open Research Fund from Beijing Advanced Innovation Center for Big Data-Based Precision Medicine, Beijing Tongren Hospital, Beihang University; Capital Medical University [BHTR-KFJJ-202009]; Beijing Hospitals Authority Youth Programme [QML20200201]

作者

  • Y

    Yang, Jing (第一作者)

    capital med univ

  • L

    Li, Pengfei

    southern med univ · sun yat sen univ

查看全部 8 位作者收起作者
  • P

    Piao, Yingshi

    capital med univ

  • L

    Liu, Xindi

    capital med univ

  • W

    Wei, Liqiang

    capital med univ

  • S

    Sang, Wei (通讯)

    xuzhou med univ

  • Z

    Zhang, Luo (通讯)

    capital med univ · beijing inst otolaryngol

  • W

    Wang, Liang (通讯)

    capital med univ · beihang univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417